NM_000726.5:c.1027C>G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_000726.5(CACNB4):c.1027C>G(p.Gln343Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000102 in 1,574,604 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000726.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNB4 | ENST00000539935.7 | c.1027C>G | p.Gln343Glu | missense_variant | Exon 12 of 14 | 1 | NM_000726.5 | ENSP00000438949.1 | ||
ENSG00000283228 | ENST00000637559.1 | n.*57C>G | non_coding_transcript_exon_variant | Exon 9 of 12 | 5 | ENSP00000489697.1 | ||||
ENSG00000283228 | ENST00000637559.1 | n.*57C>G | 3_prime_UTR_variant | Exon 9 of 12 | 5 | ENSP00000489697.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152166Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000844 AC: 12AN: 1422438Hom.: 0 Cov.: 25 AF XY: 0.00000283 AC XY: 2AN XY: 706826
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1027C>G (p.Q343E) alteration is located in exon 12 (coding exon 12) of the CACNB4 gene. This alteration results from a C to G substitution at nucleotide position 1027, causing the glutamine (Q) at amino acid position 343 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Idiopathic generalized epilepsy Uncertain:1
This sequence change replaces glutamine with glutamic acid at codon 343 of the CACNB4 protein (p.Gln343Glu). The glutamine residue is highly conserved and there is a small physicochemical difference between glutamine and glutamic acid. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with CACNB4-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at